This company has been marked as potentially delisted and may not be actively trading.

TradeUP Acquisition (UPTD) Competitors

UPTD vs. FNCH, NKGN, ZIVO, SQZ, and SRNE

Should you be buying TradeUP Acquisition stock or one of its competitors? The main competitors of TradeUP Acquisition include Finch Therapeutics Group (FNCH), NKGen Biotech (NKGN), ZIVO Bioscience (ZIVO), SQZ Biotechnologies (SQZ), and Sorrento Therapeutics (SRNE). These companies are all part of the "biological products, except diagnostic" industry.

How does TradeUP Acquisition compare to Finch Therapeutics Group?

TradeUP Acquisition (NASDAQ:UPTD) and Finch Therapeutics Group (NASDAQ:FNCH) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, media sentiment, earnings, risk, institutional ownership and valuation.

: TradeUP Acquisition's return on equity of 0.00% beat Finch Therapeutics Group's return on equity.
Company Net Margins Return on Equity Return on Assets
TradeUP Acquisition N/A N/A -3.38%
Finch Therapeutics Group N/A -69.14% -26.92%
: 35.0% of TradeUP Acquisition shares are held by institutional investors. Comparatively, 21.8% of Finch Therapeutics Group shares are held by institutional investors. 55.1% of TradeUP Acquisition shares are held by insiders. Comparatively, 44.9% of Finch Therapeutics Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
: TradeUP Acquisition has a beta of 0.12, indicating that its stock price is 88% less volatile than the S&P 500. Comparatively, Finch Therapeutics Group has a beta of 1.18, indicating that its stock price is 18% more volatile than the S&P 500.
: Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
TradeUP Acquisition N/A N/A -$1M N/A N/A
Finch Therapeutics Group N/A N/A -$74.75M -$8.82 N/A
: In the previous week, TradeUP Acquisition's average media sentiment score of 0.67 beat Finch Therapeutics Group's score of 0.00 indicating that TradeUP Acquisition is being referred to more favorably in the media.
Company Overall Sentiment
TradeUP Acquisition Positive
Finch Therapeutics Group Neutral

Company	Net Margins	Return on Equity	Return on Assets
TradeUP Acquisition	N/A	N/A	-3.38%
Finch Therapeutics Group	N/A	-69.14%	-26.92%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TradeUP Acquisition	N/A	N/A	-$1M	N/A	N/A
Finch Therapeutics Group	N/A	N/A	-$74.75M	-$8.82	N/A

Company	Overall Sentiment
TradeUP Acquisition	Positive
Finch Therapeutics Group	Neutral

Summary

TradeUP Acquisition beats Finch Therapeutics Group on 6 of the 7 factors compared between the two stocks.

How does TradeUP Acquisition compare to NKGen Biotech?

TradeUP Acquisition (NASDAQ:UPTD) and NKGen Biotech (NYSE:NKGN) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, analyst recommendations, dividends, media sentiment, earnings, institutional ownership and valuation.

: Company Net Margins Return on Equity Return on Assets
TradeUP Acquisition N/A N/A -3.38%
NKGen Biotech N/A N/A -479.36%
: 35.0% of TradeUP Acquisition shares are owned by institutional investors. Comparatively, 76.2% of NKGen Biotech shares are owned by institutional investors. 55.1% of TradeUP Acquisition shares are owned by insiders. Comparatively, 10.4% of NKGen Biotech shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
: TradeUP Acquisition has a beta of 0.12, indicating that its share price is 88% less volatile than the S&P 500. Comparatively, NKGen Biotech has a beta of 0.82, indicating that its share price is 18% less volatile than the S&P 500.
: Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
TradeUP Acquisition N/A N/A -$1M N/A N/A
NKGen Biotech N/A N/A -$82.94M -$1.51 N/A
: In the previous week, TradeUP Acquisition's average media sentiment score of 0.67 beat NKGen Biotech's score of 0.00 indicating that TradeUP Acquisition is being referred to more favorably in the media.
Company Overall Sentiment
TradeUP Acquisition Positive
NKGen Biotech Neutral

Company	Net Margins	Return on Equity	Return on Assets
TradeUP Acquisition	N/A	N/A	-3.38%
NKGen Biotech	N/A	N/A	-479.36%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TradeUP Acquisition	N/A	N/A	-$1M	N/A	N/A
NKGen Biotech	N/A	N/A	-$82.94M	-$1.51	N/A

Company	Overall Sentiment
TradeUP Acquisition	Positive
NKGen Biotech	Neutral

Summary

TradeUP Acquisition beats NKGen Biotech on 4 of the 6 factors compared between the two stocks.

How does TradeUP Acquisition compare to ZIVO Bioscience?

TradeUP Acquisition (NASDAQ:UPTD) and ZIVO Bioscience (NASDAQ:ZIVO) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, analyst recommendations, dividends, media sentiment, earnings, institutional ownership and valuation.

: TradeUP Acquisition has a beta of 0.12, indicating that its share price is 88% less volatile than the S&P 500. Comparatively, ZIVO Bioscience has a beta of 0.04, indicating that its share price is 96% less volatile than the S&P 500.
: Company Net Margins Return on Equity Return on Assets
TradeUP Acquisition N/A N/A -3.38%
ZIVO Bioscience N/A N/A -2,240.92%
: In the previous week, TradeUP Acquisition's average media sentiment score of 0.67 beat ZIVO Bioscience's score of 0.00 indicating that TradeUP Acquisition is being referred to more favorably in the media.
Company Overall Sentiment
TradeUP Acquisition Positive
ZIVO Bioscience Neutral
: TradeUP Acquisition has higher earnings, but lower revenue than ZIVO Bioscience.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
TradeUP Acquisition N/A N/A -$1M N/A N/A
ZIVO Bioscience $15.85K 1,073.09 -$7.78M -$2.18 N/A
: 35.0% of TradeUP Acquisition shares are owned by institutional investors. Comparatively, 12.8% of ZIVO Bioscience shares are owned by institutional investors. 55.1% of TradeUP Acquisition shares are owned by insiders. Comparatively, 48.9% of ZIVO Bioscience shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Company	Net Margins	Return on Equity	Return on Assets
TradeUP Acquisition	N/A	N/A	-3.38%
ZIVO Bioscience	N/A	N/A	-2,240.92%

Company	Overall Sentiment
TradeUP Acquisition	Positive
ZIVO Bioscience	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TradeUP Acquisition	N/A	N/A	-$1M	N/A	N/A
ZIVO Bioscience	$15.85K	1,073.09	-$7.78M	-$2.18	N/A

Summary

TradeUP Acquisition beats ZIVO Bioscience on 6 of the 7 factors compared between the two stocks.

How does TradeUP Acquisition compare to SQZ Biotechnologies?

SQZ Biotechnologies (NYSE:SQZ) and TradeUP Acquisition (NASDAQ:UPTD) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, analyst recommendations, dividends, media sentiment, earnings and institutional ownership.

: SQZ Biotechnologies has a beta of 2.34, suggesting that its share price is 134% more volatile than the S&P 500. Comparatively, TradeUP Acquisition has a beta of 0.12, suggesting that its share price is 88% less volatile than the S&P 500.
: TradeUP Acquisition has a net margin of 0.00% compared to SQZ Biotechnologies' net margin of -369.96%. TradeUP Acquisition's return on equity of 0.00% beat SQZ Biotechnologies' return on equity.
Company Net Margins Return on Equity Return on Assets
SQZ Biotechnologies -369.96% -119.83% -59.90%
TradeUP Acquisition N/A N/A -3.38%
: In the previous week, TradeUP Acquisition's average media sentiment score of 0.67 beat SQZ Biotechnologies' score of 0.00 indicating that TradeUP Acquisition is being referred to more favorably in the news media.
Company Overall Sentiment
SQZ Biotechnologies Neutral
TradeUP Acquisition Positive
: TradeUP Acquisition has lower revenue, but higher earnings than SQZ Biotechnologies.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
SQZ Biotechnologies $18.16M 0.04 -$79.46M -$2.61 N/A
TradeUP Acquisition N/A N/A -$1M N/A N/A
: 38.5% of SQZ Biotechnologies shares are owned by institutional investors. Comparatively, 35.0% of TradeUP Acquisition shares are owned by institutional investors. 16.0% of SQZ Biotechnologies shares are owned by company insiders. Comparatively, 55.1% of TradeUP Acquisition shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Company	Net Margins	Return on Equity	Return on Assets
SQZ Biotechnologies	-369.96%	-119.83%	-59.90%
TradeUP Acquisition	N/A	N/A	-3.38%

Company	Overall Sentiment
SQZ Biotechnologies	Neutral
TradeUP Acquisition	Positive

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SQZ Biotechnologies	$18.16M	0.04	-$79.46M	-$2.61	N/A
TradeUP Acquisition	N/A	N/A	-$1M	N/A	N/A

Summary

TradeUP Acquisition beats SQZ Biotechnologies on 6 of the 9 factors compared between the two stocks.

How does TradeUP Acquisition compare to Sorrento Therapeutics?

TradeUP Acquisition (NASDAQ:UPTD) and Sorrento Therapeutics (NASDAQ:SRNE) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, analyst recommendations, institutional ownership, profitability and media sentiment.

: TradeUP Acquisition has higher earnings, but lower revenue than Sorrento Therapeutics.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
TradeUP Acquisition N/A N/A -$1M N/A N/A
Sorrento Therapeutics $60.32M 0.01 -$572.84M -$0.43 N/A
: Company Net Margins Return on Equity Return on Assets
TradeUP Acquisition N/A N/A -3.38%
Sorrento Therapeutics N/A N/A N/A
: In the previous week, TradeUP Acquisition's average media sentiment score of 0.67 beat Sorrento Therapeutics' score of 0.00 indicating that TradeUP Acquisition is being referred to more favorably in the media.
Company Overall Sentiment
TradeUP Acquisition Positive
Sorrento Therapeutics Neutral
: TradeUP Acquisition has a beta of 0.12, meaning that its stock price is 88% less volatile than the S&P 500. Comparatively, Sorrento Therapeutics has a beta of 0.3, meaning that its stock price is 70% less volatile than the S&P 500.
: 35.0% of TradeUP Acquisition shares are held by institutional investors. Comparatively, 0.0% of Sorrento Therapeutics shares are held by institutional investors. 55.1% of TradeUP Acquisition shares are held by company insiders. Comparatively, 2.6% of Sorrento Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TradeUP Acquisition	N/A	N/A	-$1M	N/A	N/A
Sorrento Therapeutics	$60.32M	0.01	-$572.84M	-$0.43	N/A

Company	Net Margins	Return on Equity	Return on Assets
TradeUP Acquisition	N/A	N/A	-3.38%
Sorrento Therapeutics	N/A	N/A	N/A

Company	Overall Sentiment
TradeUP Acquisition	Positive
Sorrento Therapeutics	Neutral

Summary

TradeUP Acquisition beats Sorrento Therapeutics on 4 of the 7 factors compared between the two stocks.

Get TradeUP Acquisition News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UPTD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

UPTD vs. The Competition

Export

Metric	TradeUP Acquisition	Biological Products Industry	Medical Sector	NASDAQ Exchange
Market Cap	$3.73M	$329.01M	$6.25B	$11.77B
Dividend Yield	N/A	N/A	2.74%	5.26%
P/E Ratio	N/A	N/A	29.25	27.07
Price / Sales	N/A	189.48	504.68	73.47
Price / Cash	N/A	22.44	43.30	53.90
Price / Book	-1.08	4.73	9.67	6.69
Net Income	-$1M	-$132.96M	$3.55B	$332.64M

TradeUP Acquisition Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
UPTD TradeUP Acquisition	N/A	$1.72 +26.5%	N/A	N/A	$3.73M	N/A	N/A	2,021	Gap Down High Trading Volume
FNCH Finch Therapeutics Group	N/A	$8.27 -1.8%	N/A	N/A	$13.28M	N/A	N/A	190
NKGN NKGen Biotech	N/A	$0.06 flat	N/A	N/A	$7.84M	N/A	N/A	N/A
ZIVO ZIVO Bioscience	N/A	$1.17 -2.5%	N/A	N/A	$4.68M	$15.85K	N/A	10	Gap Up High Trading Volume
SQZ SQZ Biotechnologies	N/A	$0.02 flat	N/A	N/A	$708K	$18.16M	N/A	1,620

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:UPTD) was last updated on 5/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

TradeUP Acquisition (UPTD) Competitors

UPTD vs. FNCH, NKGN, ZIVO, SQZ, and SRNE

How does TradeUP Acquisition compare to Finch Therapeutics Group?

Summary

How does TradeUP Acquisition compare to NKGen Biotech?

Summary

How does TradeUP Acquisition compare to ZIVO Bioscience?

Summary

How does TradeUP Acquisition compare to SQZ Biotechnologies?

Summary

How does TradeUP Acquisition compare to Sorrento Therapeutics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

UPTD vs. The Competition

TradeUP Acquisition Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

TradeUP Acquisition (UPTD) Competitors

UPTD vs. FNCH, NKGN, ZIVO, SQZ, and SRNE

How does TradeUP Acquisition compare to Finch Therapeutics Group?

Summary

How does TradeUP Acquisition compare to NKGen Biotech?

Summary

How does TradeUP Acquisition compare to ZIVO Bioscience?

Summary

How does TradeUP Acquisition compare to SQZ Biotechnologies?

Summary

How does TradeUP Acquisition compare to Sorrento Therapeutics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

UPTD vs. The Competition

TradeUP Acquisition Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools